UNSPSC 41131704: Activated whole blood clotting time tests

In this classification an activated whole blood clotting time tests is a device, used to monitor heparin therapy for the treatment of venous thrombosis or pulmonary embolism by measuring the coagulation time of whole blood US FDA regulates Activated whole blood clotting time tests under 21 CFR 864.7140 and under FDA product code JBP.

UNSPSC 41131704 Activated whole blood clotting time tests is a Commodity code that does not align with actual state and local procurement activity under the code's nominal scope. The recent opportunities posted under this code include offender drug testing services, laboratory consumables for forensic and genetic analysis, occupational health screenings, urinalysis testing, and drug reference standards—none of which involve activated whole blood clotting time testing. The mismatch suggests the code has been misapplied to opportunities that fall outside clotting-time diagnostics and indicates minimal relevant recent activity under the code's true scope.

The issuing bodies posting under this code span county and state agencies, including Collin County Community Supervision and Corrections Department and Collin County Health Care Services in Texas, Gwinnett County in Georgia, the Texas Comptroller of Public Accounts, the City of Charlotte, Bernalillo County in New Mexico, the University of Wisconsin-Madison, Seminole County in Florida, Benton County in Oregon, the State of Oregon, and Pinellas County in Florida. Geographic spread covers Texas, Georgia, North Carolina, New Mexico, Wisconsin, Florida, and Oregon. Representative opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated contract value $600,000), Benton County's request for proposals for urinalysis testing to support the Family Treatment Court Program (due July 7, 2026), and the Texas Comptroller's IFB 304T-27-175A1.1 for proprietary chemical laboratory equipment and supplies including forensic and drug-screening consumables (due October 20, 2026). The code shows no genuine activity in activated whole blood clotting time diagnostics and warrants reclassification or verification against the actual solicitation scope.